BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Demyelinating Autoimmune CNS

Below is an extended Demyelinating Autoimmune CNS research listing. Click here to return to the Demyelinating Autoimmune CNS main in depth entry.

Recent Publications on Demyelinating Autoimmune CNS:

Acute disseminated encephalomyelitis.
Acute disseminated encephalomyelitis (ADEM), which is classified as a...
Direct Link
4th October, 2008
Neurological Institute-Foundation IRCCS C. Mondino, Pavia, Italy.
Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis.
Multiple sclerosis (MS) is the most common non-traumatic, disabling...
Direct Link
4th October, 2008
Department of Parasitology, Microbiology and Immunology, Biological
Cerebrospinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions.
BACKGROUND: In many neuroinflammatory diseases, dendritic cells (DCs)...
Direct Link
3rd October, 2008
INSERM, U842, Lyon, France.
Combined medication of lovastatin with rolipram suppresses severity of experimental autoimmune encephalomyelitis.
Combinations of new medications or existing therapies are gaining momentum...
Direct Link
9th September, 2008
Darby Children's Research Institute, Medical University of South Carolina,
Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis.
BACKGROUND: Multiple sclerosis (MS) is an immune mediated demyelinating...
Direct Link
6th September, 2008
The Hadassah Human Embryonic Stem Cells Research Center, The Goldyne Savad
Chapter 4 B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases.
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of...
Direct Link
6th September, 2008
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute,
Altered lipid metabolism in brain injury and disorders.
Deregulated lipid metabolism may be of particular importance for CNS...
Direct Link
30th August, 2008
Department of Neurological Surgery, Cardiovascular Research Center,
The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the...
Direct Link
30th August, 2008
University of Wurzburg, Department of Neurology, Wurzburg, Germany.
[Neuro-Behcet's disease: MR-imaging findings]
Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated,...
Direct Link
30th August, 2008
Tubingen.
Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.
Drug combination therapies for central nervous system (CNS) demyelinating...
Direct Link
23rd August, 2008
Department of Pediatrics, Medical University of South Carolina,
Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis.
Multiple sclerosis and experimental autoimmune encephalomyelitis (EAE)...
Direct Link
23rd August, 2008
Department of Neurology, David Geffen School of Medicine at University of
Nogo-A and myelin-associated glycoprotein differently regulate oligodendrocyte maturation and myelin formation.
Nogo-A is one of the most potent oligodendrocyte-derived inhibitors for...
Direct Link
13th August, 2008
Department of Biology, Brain Research Institute, University of Zurich,
Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents. 13th August, 2008
Max-Planck-Institut fur Biochemie, Abteilung Strukturforschung,
Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.
Experimental autoimmune encephalomyelitis (EAE) is a T cell-mediated,...
Direct Link
6th August, 2008
Department of Pathology, Feinberg School of Medicine, Northwestern
Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis.
Multiple sclerosis (MS) is a chronic, inflammatory, demyelinating disease...
Direct Link
23rd July, 2008
*Department of Clinical Neurosciences, Neuroimmunology Unit, Karolinska
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional